where in the thigh to inject semaglutide Semaglutide: Optimal Sites for Maximum Efficacy where to inject glp-1 in

Patients with cardiovascular history, hypertension, or metabolic syndrome warrant closer monitoring during discontinuation

Review the storage section above

Learn more about GLP-1s View our full collection of GLP-1 Insights articles to stay up to date with the latest information on this high-profile drug class.

Conclusions GLP-1 agonists reduce fetal survival, weight, growth and skeletal ossification and can induce major congenital anomalies

Although this was an exploratory post hoc analysis, it is noteworthy that observed group differences suggested a trend toward bone loss, with consistently lower BMD and increased bone turnover at follow-up in the semaglutide + lifestyle counseling group compared to that in the lifestyle counseling alone